| 标题 |
[求助补充材料]
 Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Criminology34
Kao
cat
GingerF
Nole
张欢馨
OK
ming2026
小小牛马
渡人舟
东方元语
loii
yjh123
vampv
失眠翠芙
牧青
笑点低的翠
归尘
dynamoo
皖公网安备34019202002308
